Yurtdışı Yayınlar

    1. Pay S, Ozcan N, Tokgozoglu SL. Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesteol levels. International Journal of Cardiology 60: 301-305, 1997. Ozturk E, Gunalp B, Mas R, Ozguven M, Dinc A, Bayhan H. Evaluation of hepatocyte function after extracorporeal shock wave lithotripsy with hepatobiliary scintigraphy.
      Am J Gastroenterol. 1998 Oct;93(10):1905-8.
    2. Kocar IH, Caliskaner Z, Pay S, Turan M.  Clostridium difficile infection in patients with reactive arthritis of undetermined etiology. Scandinavian Journal of Rheumatology 27: 357-362, 1998
    3. Mas MR, Saglamkaya U, Kubar A, Colakoglu M, Ateskan U, Erdem H, Nalbant S, Eyileten T, Comert B, Unal T, Kocabalkan F.  Hepatitis G virus infection among patients undergoing hemodialysis. Nephron. 1998 Oct;80(2):247-8.
    4. Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S.  Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clinical and Experimental Rheumatology 16: 721-724, 1998
    5. Calguneri M, Pay S, Caliskaner Z, Apras S, Kiraz S, Ertenli I, Cobankara V. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 17: 699-704, 1999.
    6. Simsek I, Dinc A, Mas MR, Gunhan O, Kocabalkan F. Behcet's disease with a cecal perforation.
      Clin Exp Rheumatol. 2000 Mar-Apr;18(2):268-9. No abstract available
    7. Pay S, Calguneri M, Caliskaner Z, Dinc A, Apras S, Ertenli I, Kiraz S, Cobankara V.  Evaluation of Vascular Injury with Proinflammatory Cytokines, Thrombomodulin and Fibronectin in Patients with Primary Fibromyalgia. Nagoya Journal of Medical Science 63: 115-122, 2000.
    8. Dinc A, Soy M, Pay S, Simsek I, Erdem H, Sobaci G. Case of Churg-Strauss Syndrome presenting with cortical blindness. Clinical Rheumatology 19: 318-320, 2000.
    9. Dinc A, Simsek I, Pay S, Caglar K, Can C. Fabry’s Disease mimicking Familial Mediterranean Fever. Clinical and Experimental Rheumatology 18: 787-788, 2000.
    10. Pay S, Dinc A, Simsek I, Can C, Erdem H.  Sulphasalazine induced angioimmunoblastic lymphadenopathy. Rheumatology International 20: 25-27, 2000.
    11. Dinc A, Karaayvaz M, Caliskaner AZ, Pay S, Erdem H, Turan M. Dermographism and Atopy in Patients with Behçet’s Disease. Journal of Allergology and Clinical Immunology 10:368-371, 2000.
    12. Mas MR, Simsek I, Can C, Ateskan U, Erdem H, Kocabalkan F.  Fulminant hepatic failure as the initial manifestation of primary hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2000 May;12(5):575-8.
    13. Simsek I, Mas MR, Yasar M, Ozyurt M, Saglamkaya U, Deveci S, Comert B, Basustaoglu A, Kocabalkan F, Refik M. Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis. Pancreas. 2001 Oct;23(3):296-301.
    14. H. Erdem, K. Sağlam, M.İ. Yılmaz, M. Güleç, F. Bulucu. The investigation of Insulin Resistance with Hyperinsulinemic Euglycemic Clamp Technique in Premature Coronary Artery Disease. International Journal of Medicine, Biology and the Enviroment.Vol 29 (1) 2001
    15. Comert B, Mas MR, Erdem H, Dinc A, Saglamkaya U, Cigerim M, Kuzhan O, Unal T, Kocabalkan F. Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis. 2001 May;33(4):353-8.
    16. Saglamkaya U, Mas MR, Yasar M, Simsek I, Mas NN, Kocabalkan F. Penetration of meropenem and cefepim into pancreatic tissue during the course of experimental acute pancreatitis. Pancreas. 2002 Apr;24(3):264-8.
    17. Pay S, Erdem H, Serdar M, Dinc A, Simsek I, Turan M. Comparison of Synovial MMP-1 and TIMP-1 Levels in Patients with Various Inflammatory Arthritides: Is There Any Difference Between Rheumatoid Arthritis, Behçet’s Disease and Familial Mediterranean Fever? Clinical Rheumatology 21:511-515, 2002
    18. Calguneri M, Cobankara V, Ozatli D, Guler G, Apras S, Pay S, Kiraz S, Ertenli I, Ozturk MA. Is visual loss due to giant cell arteritis reversible? Yonsei Medical Journal 44:155-158, 2003
    19. Ozturk M, Mas MR, Yasar M, Akay C, Aydogan H, Deveci S, Comert B, Simsek I, Mas N, Kocar IH. The role of inducible nitric oxide synthase inhibitor, meropenem, and taurine in experimental acute necrotizing pancreatitis.Pancreas. 2003 May;26(4):357-62.
    20. Ozturk M, Mas MR, Yasar M, Akay C, Aydogan H, Deveci S, Comert B, Simsek I, Mas N, Kocar IH. The role of inducible nitric oxide synthase inhibitor, meropenem, and taurine in experimental acute necrotizing pancreatitis.Pancreas. 2003 May;26(4):357-62.
    21. Pay S, Terkeltaub R. Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician. Curr Rheumatol Rep. 5:235-243, 2003.
    22. Pay S, Terkeltaub AR. The case for uricase in gout. Curr Rheumatol Rep. 2003 Jun;5(3):213-4
    23. Apras S, Ertenli I, Ozbalkan Z, Kiraz S, Ozturk MA, Haznedaroglu IC, Cobankara V, Pay S, Calguneri M. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum. 48:2256-2261, 2003
    24.  Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI. Antiannexin V autoantibody in thrombophilic Behcet's disease. Rheumatol Int. 2003 Dec 5
    25. Yesilova Z, Pay S, Oktenli C, Musabak U, Saglam K, Sanisoglu SY, Dagalp K, Erbil MK, Kocar IH. Hyperhomocysteinemia in patients with Behcet's disease: is it due to inflammation or therapy?Rheumatol Int. 2004 Apr 1
    26. Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S. Does immune activation continue during an attack-free period in familial Mediterranean fever?Clin Exp Immunol. 2004 Dec;138(3):526-33.
    27. Erdem H, Pay S, Serdar M, Simsek I, Dinc A, Musabak U, Pekel A, Turan M. Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behcet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis.
      Rheumatol Int. 2004 Nov 3
    28. Turkish FMF Study Group. Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study.Medicine (Baltimore). 2005 Jan;84(1):1-11.
    29. Çobankara V, Öztürk MA, Kiraz S, Ertenli İ, Haznedaroğlu İC, Pay S, Çalgüneri M. Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis. Rheumatol Int. 2005 May;25(4):285-91.
    30. Liu-Bryan R, Pay S, Schraufstatter IU, Rose DM. The CXCR1 tail mediates beta1 integrin-dependent cell migration via MAP kinase signaling. Biochem Biophys Res Commun. 2005 Jun 24;332(1):117-25.
    31. Pay S, Musabak U, Erdem H, Şimşek İ, Pekel A, Şengül A, Dinç A. Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. Immunopharmacol Immunotoxicol. 2005;27(2):187-98.
    32. Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behcet's patients with venous thrombosis. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S42-8.
    33. Dinc A, Bayir A, Simsek I, Erdem H, Pay S, Turan M. The proportional Venn diagram of Behcet's disease-related manifestations among young adult men in Turkey. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S86-90.
    34. Dinc A, Erdem H, Rowczenio D, Simsek I, Pay S, Bahce M, Lachmann H. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family. J Nephrol. 2005 Sep-Oct;18(5):626-9.
    35. Erdem H, Simsek I, Pay S, Dinc A, Deniz O, Ozcan A. Diffuse pulmonary amyloidosis that mimics interstitial lung disease in a patient with familial Mediterranean fever. J Clin Rheumatol. 2006 Feb;12(1):34-6. 
    36. Erdem H, Dinc A, Pay S, Simsek I, Turan M. Peripheral insulin resistance in patients with Behcet's disease. J Eur Acad Dermatol Venereol. 2006 Apr;20(4):391-5.
    37. Pay S, Musabak U, Simsek I, Pekel A, Erdem H, Dinc A, Sengul A. Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: Does persistent or increasing expression of CXCR-2 contribute to the chronic inflammation or erosive changes? Joint Bone Spine. 2006 Dec 73(6): 691-6
    38. Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A Synovial Proinflammatory Cytokines and Their Correlation with Matrix Metalloproteinase-3 Expression in Behçet’s Disease.  Does Interleukin-1b Play a Major Role in Behçet’s Synovitis? Rheumatol Int. 2006 ;26(7):608-13
    39. Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Serum Interleukin-18 Levels in Patients with Behçet’s Disease: Is Its Expression Associated with Disease Activity or Clinical Presentations? Rheumatol Int. 2006;26(6):545-50
    40. Erdem H, Dinc A, Pay S, Simsek I, Uysal Y. A neuro-Behcet's case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt. Joint Bone Spine. 2006 Mar; 73(2): 200-1
    41. Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I, Ozturk MA, Duzgun N, Erdem H, Ozbalkan Z, Kiraz S, Kinikli G, Besbas N, Dinc A, Ates A, Olmez U, Calguneri M, Tiryaki Aydintug O, Bakkaloglu A, Turan M, Turgay M, Karaaslan Y, Topaloglu R, Duman M, Ozen S; Ankara Rheumatology Study Group. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006 Sep; 25(5): 639-644.
    42. Simsek I, Pay S, Dinc A, Erdem H, Kurt B. Atypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment-case report. Clin Rheumatol. 2007 Sep;26(9):1561-2.
    43. Simsek I, Pay S, Dinc A, Erdem H, Kurt B. Atypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment-case report. Clin Rheumatol. 2007 Sep;26(9):1561-2.
    44. Pay S, Şimşek İ, Erdem H, Dinç A.  Immunopathogenesis of Behçet’s Disease with Special Emphasize on the Possible Role of Antigen Presenting Cells. Rheumatology Int 2007 Mar; 27(5):417-424
    45. Erdem H, Pay S, Musabak U, Simsek I, Dinc A, Pekel A, Sengul A. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?
      Rheumatol Int. 2007 Aug;27(10):969-73.
    46. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever.
      Rheumatol Int. 2007 Jul;27(9):807-11.
    47. Simsek I, Erdem H, Pay S, Sobaci G, Dinc A. Optic neuritis occurring with anti-Tumor Necrosis Factor-{alpha} therapy. Ann Rheum Dis. 2007 Sep;66(9):1255-8.
    48. Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5. 
    49. Pay S, Simsek I, Erdem H, Pekel A, Musabak U, Sengul A, Dinc A. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S34-40. 
    50. Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S21-6. 
    51. Saruhan-Direskeneli G, Inanc M, Fresko I, Akkoc N, Dalkilic E, Erken E, Karaaslan Y, Kinikli G, Oksel F, Pay S, Yucel E, Yentür SP, Duymaz-Tozkir J, Yilmaz V, Inanc N, Yazici H, Konice M, Direskeneli H. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis. Rheumatology (Oxford). 2007; 46(12):1842-4.
    52. Pay S, Şimşek İ, Erdem H, Dinç A.  Immunopathogenesis of Behçet’s Disease with Special Emphasize on the Possible Role of Antigen Presenting Cells. Rheumatology Int 2007 Mar; 27(5):417-424
    53. Erdem H, Pay S, Musabak U, Simsek I, Dinc A, Pekel A, Sengul A. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?
      Rheumatol Int. 2007 Aug;27(10):969-73.
    54. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever.
      Rheumatol Int. 2007 Jul;27(9):807-11.
    55. Simsek I, Erdem H, Pay S, Sobaci G, Dinc A. Optic neuritis occurring with anti-Tumor Necrosis Factor-{alpha} therapy. Ann Rheum Dis. 2007 Sep;66(9):1255-8.
    56. Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5. 
    57. Pay S, Simsek I, Erdem H, Pekel A, Musabak U, Sengul A, Dinc A. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S34-40. 
    58. Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis? Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S21-6. 
    59. Saruhan-Direskeneli G, Inanc M, Fresko I, Akkoc N, Dalkilic E, Erken E, Karaaslan Y, Kinikli G, Oksel F, Pay S, Yucel E, Yentür SP, Duymaz-Tozkir J, Yilmaz V, Inanc N, Yazici H, Konice M, Direskeneli H. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis. Rheumatology (Oxford). 2007; 46(12):1842-4.
    60. Pay S; Society for Research and Education in Rheumatology of Turkey. Risk of cancer in Turkish patients after treatment with TNF antagonists. Rheumatology (Oxford). 2008 Apr;47(4):548-9.
    61. Cinar M, Dinc A, Simsek I, Erdem H, Koc B, Pay S, Tunca Y, Kilic S, Gul D. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008 Nov;29(1):37-42.
    62. Simsek I, Cinar M, Erdem H, Pay S, Meric C, Dinc A.  Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis-like acute cutaneous lupus erythematosus. Lupus. 2008;17(6):605-6.
    63. Simsek I, Meric C, Erdem H, Pay S, Kilic S, Dinc A. Accuracy of recall of the items included in disease activity forms of Behçet's disease: comparison of retrospective questionnaires with a daily telephone interview. Clin Rheumatol. 2008 Oct;27(10):1255-60.
    64. Simsek I, de Mazancourt P, Horellou MH, Erdem H, Pay S, Dinc A, Samama MM. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Blood Coagul Fibrinolysis. 2008 Apr;19(3):247-53.
    65. Köse O, Dinc A, Simsek I. Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease. Dermatology. 2009;218(2):140-5.
    66. Sari I, Simsek I, Guvenc I, Sanal HT, Erdem H, Pay S, Dinc A. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009 Jan;29(3):321-3.
    67. Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H, Direskeneli H, Gunaydin Y, Dinc A. The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study. J Oral Pathol Med. 2009 Mar 5.
    68. Kisacik B, Kasifoglu T, Akay S, Yilmaz O, Yilmaz S, Simsek I, Erdem H, Pay S, Dinc A. Ulnar artery aneurysm in a patient with Behçet's disease. Rheumatol Int. 2009 May 20.
    69. Kiliç H, Zeytin HE, Korkmaz C, Mat C, Gül A, Coşan F, Dinç A, Simşek I, Süt N, Yazici H. Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome. Rheumatology (Oxford). 2009 Nov;48(11):1388-91. Epub 2009 Aug 28.
    70. Basaran Y, Simsek I, Gunal A. Celiac disease with a mixed pattern: a case report. Cases J. 2009 Dec 16;2:9330.
    71. Simsek I, Yazici Y. Safety and clinical efficacy of golimumab in the treatment of arthritides. Drug Healthc Patient Saf. 2010;2:169-80. Epub 2010 Sep 28.
    72. Kisacik B, Oren C, Kasifoglu T, Yilmaz S, Yilmaz O, Simsek I, Erdem H, Pay S, Saglam M, Dinc A. Investigation of the veins in patients with Behçet's disease with no known vascular event by Doppler ultrasonography. Rheumatol Int. 2010 Oct 28. [Epub ahead of print]
    73. Simsek I. TNF inhibitors - new and old agents for rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2010;68(3):204-10. Review.
    74. Yazici Y, Simsek I. Treatment options for rheumatoid arthritis beyond TNF-α inhibitors. Expert Rev Clin Pharmacol. 2010 Sep;3(5):663-6.
    75. Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010 Oct;69(10):1809-15. Epub 2010 Jun 15.
    76. Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy. J Nephrol. 2010 Jan-Feb;23(1):119-23.
    77. Sanal HT, Yilmaz S, Cinar M, Simsek I, Dinc A, Tayfun C. Onycho-Pachydermatit with extensive bone marrow edema predominant in the metacarpals: a "forme fruste" of POPP? Rheumatol Int. 2011 Mar 30. [Epub ahead of print].
    78. Yilmaz O, Yilmaz S, Kisacik B, Aydogdu M, Bozkurt Y, Erdem H, Pay S, Saglam M, Dinc A. Varicocele and epididymitis in Behcet disease. J Ultrasound Med. 2011 Jul;30(7):909-13
    79. Cinar FI, Unver V, Yilmaz S, Cinar M, Yilmaz F, Simsek I, Erdem H, Pay S, Dinc A. Living with scleroderma: patients' perspectives, a phenomenological study. Rheumatol Int. 2011 Nov 17. [Epub ahead of print]
    80. Köse O, Simşek I, Pay S. Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases. Int J Dermatol. 2011 Jul;50(7):895-6.
    81. Simsek I, Koz C, Basar N, Sari I, Erdem H, Pay S, Kisacik B, Bahce M, Dinc A. Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease. Clin Rheumatol. 2011 Apr;30(4):491-5. Epub 2010 Jul 20.
    82. Simsek I. TNF inhibitors for rheumatoid arthritis - a year in review. Bull NYU Hosp Jt Dis. 2011;69(3):220-4. Review.
    83. Sanal HT, Yilmaz S, Kalyoncu U, Cinar M, Simsek I, Erdem H, Pay S, Dinc A, Tayfun C. Value of DWI in visual assessment of activity of sacroiliitis in longstanding ankylosing spondylitis patient. Skeletal Radiol. 2012 Jun 28. [Epub ahead of print]
    84. Gok M, Erdem H, Gogus F, Yilmaz S, Karadag O, Simsek I, Sagkan RI, Saglam M, Musabak U, Dinc A, Pay S. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides. Rheumatol Int. 2012 Jul 19. [Epub ahead of print].
    85. Karadag O, Tufan A, Yazisiz V, Ureten K, Yilmaz S, Cinar M, Akdogan A, Erdem H, Ozturk MA, Pay S, Dinc A. The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int. 2012 Jul 20. [Epub ahead of print]
    86. Sanal HT, Yilmaz S, Simsek I. Limbus vertebra. Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34630. [Epub ahead of print]
    87. Yilmaz S, Tezel K, Ocal R, Ilıca T, Cinar M, Erdem H, Pay S, Dinc A, Simsek I. Anterior Spinal Cord Syndrome in a Patient with Behçet's Disease. Bull NYU Hosp Jt Dis. 2012;70(2):120-3.
    88. Sedat Yilmaz, Muhammet Cinar, Yıldırım Karslioglu, Ismail Simsek, Hakan Erdem, Salih Pay, Ayhan Dinc. Lipid StorageMyopathy in Behc¸et’s Disease: A Rare Cause of Elevated Serum Creatine Kinases Levels. Case Reports in Rheumatology Volume 2012, Article ID 283259.
    89. Malhan S, Pay S, Ataman S, Dalkilic E, Dinc A, Erken E, Ertenli I, Ertugrul E, Gogus F, Hamuryudan V, Inanc M, Karaarslan Y, Karadag O, Karakoc Y, Keskin G, Kisacik B, Kiraz S, Oksel F, Oksuz E, Pirildar T, Sari I, Soy M, Senturk T, Taylan A. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):202-7. Epub 2012 Apr 13.
    90. Simsek I, Yazici Y. Incomplete reporting of recruitment information in clinical trials of biological agents for the treatment of rheumatoid arthritis: A review. Arthritis Care Res (Hoboken). 2012 May 3. doi: 10.1002/acr.21721. [Epub ahead of print].
 
Tasarım: GATA © 2011
Internet Explorer 7.0 ve Üzeri Web Tarayıcıları ile 1280 x 1024 Çözünürlük ve Gerçek Renk Ekran Özellikleri Tavsiye Edilmektedir.